Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masahiro Andou
A Phase I Trial of a Combination of Cisplatin and Carboplatin in Advanced Non-Small Cell Lung Cancer. An Intensification of Platinum Dose by a Combination of Two Platinum Cmpounds.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Related publications
P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase I/Ii Study of LY900003, an Antisense Inhibitor of Protein Kinase C- , in Combination With Cisplatin and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Trial of Temsirolimus and Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
Chemotherapy
Medicine
Drug Discovery
Infectious Diseases
Oncology
Pharmacology
Phase I Study of Paclitaxel and Carboplatin Combination Chemotherapy for Elderly Patients Aged 75 Years and Over With Advanced Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With Nab-Paclitaxel and Carboplatin in Advanced Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Bevacizumab in Combination With Different Platinum-Based Doublets in the First-Line Treatment for Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis
International Journal of Cancer
Cancer Research
Oncology
A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Cancer Research and Treatment
Cancer Research
Oncology
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary